Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIAMI-uk
ISRCTN28988273Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Jul 2008
- Modality
- Small Molecules
01
Overview
Phase 2 trial of melatonin in bipolar disorder (BD), sponsored by University of Oxford. Started Jul 2008; status: completed.
02
Drugs
melatonin
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on ISRCTN28988273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN28988273.